Top Markets
Coin of the day
Lifeline Biotechnologies, Inc. Lifeline Biotechnologies, Inc.

Lifeline Biotechnologies, Inc.

LLBO
Rang in aandelen #36501
Lifeline Biotechnologies, Inc. operates as a medical technology company in the... Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.
Aandeelprijs
$0.0006
Laatst gesynchroniseerd: 2026-08-14
Marktkapitalisatie
$2.61M
Verandering (1 dag)
50.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Lifeline Biotechnologies, Inc. (LLBO)

Categorie

P/B-ratio voor Lifeline Biotechnologies, Inc. (LLBO)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Lifeline Biotechnologies, Inc. is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor Lifeline Biotechnologies, Inc. van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten